| [1] |
Cichy W, Klincewicz B, Plawski A. Juvenile polyposis syndrome[J]. Arch Med Sci, 2014, 10(3): 570-577.
|
| [2] |
Howe JR, Mitros FA, Summers RW. The risk of gastrointestinal carcinoma in familial juvenile polyposis[J]. Ann Surg Oncol, 1998, 5(8): 751-756.
|
| [3] |
Burt RW, Bishop DT, Lynch HT, et al. Risk and surveillance of individuals with heritable factors for colorectal cancer. WHO Collaborating Centre for the prevention of colorectal cancer[J]. Bull World Health Organ, 1990, 68(5): 655-665.
|
| [4] |
Sayed MG, Ahmed AF, Ringold JR, et al. Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis[J]. Ann Surg Oncol, 2002, 9(9): 901-906.
|
| [5] |
Schreibman IR, Baker M, Amos C, et al. The hamartomatous polyposis syndromes: a clinical and molecular review[J]. Am J Gastroenterol, 2005, 100(2): 476-490.
|
| [6] |
Howe JR, Roth S, Ringold JC, et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis [J]. Science, 1998, 280(5366): 1086-1088.
|
| [7] |
van Leerdam ME, Roos VH, van Hooft JE, et al. Endoscopic management of polyposis syndromes: European Society of Gastrointestinal Endoscopy (ESGE) guideline [J]. Endoscopy, 2019, 51(9): 877-895.
|
| [8] |
Latchford AR, Neale K, Phillips RK, et al. Juvenile polyposis syndrome: a study of genotype, phenotype, and long-term outcome [J]. Dis Colon Rectum, 2012, 55(10): 1038-1043.
|
| [9] |
Brosens LA, van Hattem A, Hylind LM, et al. Risk of colorectal cancer in juvenile polyposis [J]. Gut, 2007, 56(7): 965-967.
|
| [10] |
Aretz S, Stienen D, Uhlhaas S, et al. High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome [J]. J Med Genet, 2007, 44(11): 702-709.
|
| [11] |
Syngal S, Brand RE, Church JM, et al. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes[J]. Am J Gastroenterol, 2015, 110(2): 223-262; quiz 63.
|
| [12] |
Ma H, Brosens LAA, Offerhaus GJA, et al. Pathology and genetics of hereditary colorectal cancer [J]. Pathology, 2018, 50(1): 49-59.
|
| [13] |
Gao XH, Li J, Zhao ZY, et al. Juvenile polyposis syndrome might be misdiagnosed as familial adenomatous polyposis: a case report and literature review [J]. BMC Gastroenterol, 2020, 20(1): 167.
|
| [14] |
McCarthy AJ, Chetty R. Smad4/DPC4 [J]. J Clin Pathol, 2018, 71(8): 661-664.
|
| [15] |
Calva-Cerqueira D, Chinnathambi S, Pechman B, et al. The rate of germline mutations and large deletions of SMAD4 and BMPR1A in juvenile polyposis [J]. Clin Genet, 2009, 75(1): 79-85.
|
| [16] |
Wain KE, Ellingson MS, McDonald J, et al. Appreciating the broad clinical features of SMAD4 mutation carriers: a multicenter chart review[J]. Genet Med, 2014, 16(8): 588-593.
|
| [17] |
O'Malley M, LaGuardia L, Kalady MF, et al. The prevalence of hereditary hemorrhagic telangiectasia in juvenile polyposis syndrome[J]. Dis Colon Rectum, 2012, 55(8): 886-892.
|
| [18] |
Heald B, Rigelsky C, Moran R, et al. Prevalence of thoracic aortopathy in patients with juvenile polyposis syndrome-hereditary hemorrhagic telangiectasia due to SMAD4 [J]. Am J Med Genet A, 2015, 167a(8): 1758-1762.
|
| [19] |
Aytac E, Sulu B, Heald B, et al. Genotype-defined cancer risk in juvenile polyposis syndrome [J]. Br J Surg, 2015, 102(1): 114-118.
|
| [20] |
Cohen S, Hyer W, Mas E, et al. Management of juvenile polyposis syndrome in children and adolescents: a position paper from the ESPGHAN polyposis working group [J]. J Pediatr Gastroenterol Nutr, 2019, 68(3): 453-462.
|
| [21] |
Matsumoto T, Umeno J, Jimbo K, et al. Clinical guidelines for diagnosis and management of juvenile polyposis syndrome in children and adults-secondary publication [J]. J Anus Rectum Colon, 2023, 7(2): 115-125.
|
| [22] |
Dal Buono A, Gaiani F, Poliani L, et al. Juvenile polyposis syndrome: An overview [J]. Best Pract Res Clin Gastroenterol, 2022, 58-59: 101799.
|
| [23] |
Blatter R, Tschupp B, Aretz S, et al. Disease expression in juvenile polyposis syndrome: a retrospective survey on a cohort of 221 European patients and comparison with a literature-derived cohort of 473 SMAD4/BMPR1A pathogenic variant carriers [J]. Genet Med, 2020, 22(9): 1524-1532.
|
| [24] |
Worby CA, Dixon JE. PTEN[J]. Annu Rev Biochem, 2014, 83:641-669.
|
| [25] |
Yehia L, Keel E, Eng C. The clinical spectrum of PTEN mutations [J]. Annu Rev Med, 2020, 71: 103-116.
|
| [26] |
Alimi A, Weeth-Feinstein LA, Stettner A, et al. Overlap of Juvenile polyposis syndrome and Cowden syndrome due to de novo chromosome 10 deletion involving BMPR1A and PTEN: implications for treatment and surveillance[J]. Am J Med Genet A, 2015, 167(6): 1305-1308.
|
| [27] |
Gallione CJ, Repetto GM, Legius E, et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4) [J]. Lancet, 2004, 363(9412): 852-859.
|
| [28] |
Sweet K, Willis J, Zhou XP, et al. Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis [J]. JAMA, 2005, 294(19): 2465-2473.
|
| [29] |
Brand F, Förster A, Christians A, et al. FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas [J]. Acta Neuropathol, 2020, 139(1): 175-192.
|
| [30] |
Weren RD, Venkatachalam R, Cazier JB, et al. Germline deletions in the tumour suppressor gene FOCAD are associated with polyposis and colorectal cancer development [J]. J Pathol, 2015, 236(2): 155-164.
|
| [31] |
MacFarland SP, Xie H, Dent MH, et al. FOCAD indel in a family with juvenile polyposis syndrome [J]. J Pediatr Gastroenterol Nutr, 2022, 75(1): 56-58.
|
| [32] |
Oncel M, Church JM, Remzi FH, et al. Colonic surgery in patients with juvenile polyposis syndrome: a case series [J]. Dis Colon Rectum, 2005, 48(1): 49-55; discussion-6.
|
| [33] |
Bell LD, Bernat JA, Rahhal R. Polygenic infantile juvenile polyposis syndrome managed with sirolimus and endoscopic polypectomy [J]. Gastroenterology Res, 2022, 15(1): 33-38.
|
| [34] |
Martín-Masot R, Cardelo Autero N, Ortiz Pérez P, et al. Sirolimus for the treatment of juvenile polyposis in childhood [J]. ACG Case Rep J, 2021, 8(8): e00646.
|
| [35] |
Boland CR, Idos GE, Durno C, et al. Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis syndromes: recommendations from the US multi-society task force on colorectal cancer [J]. Gastroenterology, 2022, 162(7): 2063-2085.
|
| [36] |
Karlsson T, Cherif H. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital [J]. Ups J Med Sci, 2018, 123(3): 153-157.
|